Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
O15016
UPID:
TRI66_HUMAN
Alternative names:
-
Alternative UPACC:
O15016; A0A2R8YEA1; Q9BQQ4
Background:
Tripartite motif-containing protein 66 plays a crucial role in cellular processes, acting primarily as a transcription repressor. Its repressive effects are mediated through the recruitment of deacetylase activity. This protein is also involved in the negative regulation of postmeiotic genes, functioning through the formation of the CBX3 complex and association with centromeres, as suggested by similarity studies.
Therapeutic significance:
Understanding the role of Tripartite motif-containing protein 66 could open doors to potential therapeutic strategies. Its involvement in transcription repression and postmeiotic gene regulation highlights its importance in cellular function and disease mechanism elucidation.